Cargando…
Understanding the Economic Value of Molecular Diagnostic Tests: Case Studies and Lessons Learned
Ten years after completion of the Human Genome Project, progress towards making “personalized medicine” a reality has been slower than expected. The reason is twofold. Firstly, the science is more difficult than expected. Secondly, limited progress has been made in aligning economic incentives to in...
Autores principales: | Towse, Adrian, Ossa, Diego, Veenstra, David, Carlson, Josh, Garrison, Louis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251388/ https://www.ncbi.nlm.nih.gov/pubmed/25562729 http://dx.doi.org/10.3390/jpm3040288 |
Ejemplares similares
-
Value-Based Pricing and Reimbursement in Personalised Healthcare: Introduction to the Basic Health Economics
por: Garrison, Louis P., et al.
Publicado: (2017) -
Augmenting Cost-Effectiveness Analysis for Uncertainty: The Implications for Value Assessment—Rationale and Empirical Support
por: Garrison, Louis P., et al.
Publicado: (2020) -
Reconciling ACEA and MCDA: is there a way forward for measuring cost-effectiveness in the U.S. healthcare setting?
por: Zamora, Bernarda, et al.
Publicado: (2021) -
APPROACHES TO IDENTIFYING, MEASURING, AND AGGREGATING ELEMENTS OF VALUE
por: Towse, Adrian, et al.
Publicado: (2013) -
The added clinical and economic value of diagnostic testing for epilepsy surgery
por: Hinde, Sebastian, et al.
Publicado: (2014)